Maximiliaan L. Notenboom, BSc; Giovanni Melina, MD, PhD; Kevin M. Veen, MD, PhD; et al.
free access
JAMA Cardiol. 2024;9(1):6-14. doi:10.1001/jamacardio.2023.4090
This post hoc analysis of a randomized clinical trial assesses long-term survival after the Ross procedure among adults.
-
Invited Commentary
The Longest Reported Outcomes of the Ross Procedure
Tsuyoshi Kaneko, MD; Maral Ouzounian, MD, PhD
JAMA Cardiol
June-Wha Rhee, MD; Raju Pillai, MD; Tianhui He, MPH; et al.
open access
JAMA Cardiol. 2024;9(1):16-24. doi:10.1001/jamacardio.2023.4105
This study examines the association between clonal hematopoiesis of indeterminate potential and cardiovascular disease in patients with multiple myeloma.
Sanjiv J. Shah, MD; Nowell Fine, MD, SM; Pablo Garcia-Pavia, MD, PhD; et al.
open access
has audio
JAMA Cardiol. 2024;9(1):25-34. doi:10.1001/jamacardio.2023.4147
This post hoc analysis of the randomized Tafamidis in Transthyretin Cardiomyopathy Clinical Trial examines the effect of tafamidis vs placebo on 30-month changes in cardiac function in patients with transthyretin amyloid cardiomyopathy.
-
Podcast:
Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy
Antonio Landi, MD; Mirvat Alasnag, MD; Dik Heg, PhD; et al.
free access
JAMA Cardiol. 2024;9(1):35-44. doi:10.1001/jamacardio.2023.4316
This comparative effectiveness study, a prespecified analysis from the MASTER DAPT trial, reports sex differences and the association of sex with outcomes among patients with high bleeding risk treated with an abbreviated vs standard dual antiplatelet therapy regimen.
Jared W. Magnani, MD, MSc; Hongyan Ning, MS; John T. Wilkins, MD, MSc; et al.
free access
JAMA Cardiol. 2024;9(1):45-54. doi:10.1001/jamacardio.2023.3990
This study attempts to calculate lifetime risk estimates of incident cardiovascular disease (CVD) and CVD subtypes and estimate years lived with and without CVD by education.
Arnab K. Ghosh, MD, MSc, MA; Sara Venkatraman, MA; Michael G. Nanna, MD, MHS; et al.
JAMA Cardiol. 2024;9(1):55-62. doi:10.1001/jamacardio.2023.4520
This cohort study investigates the association between removal of race stratification from the atherosclerotic cardiovascular pooled cohort risk equations and model performance.
Behnood Bikdeli, MD, MS; Alfonso Muriel, PhD; Carmen Rodríguez, MD; et al.
free access
JAMA Cardiol. 2024;9(1):64-70. doi:10.1001/jamacardio.2023.4356
This cohort study assesses outcomes in patients with pulmonary embolism using high-sensitivity vs conventional troponin I.